RxDoctor Payments DataLook up a doctor →

Hemindermeet Singh, MD

Cardiovascular Disease · Perrysburg, OHNPI 1821345695

Payments from drug & device makers

$295,896in general payments, 2019–2025

Across 448 payments — averaging $660.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$138K
  • Boehringer Ingelheim International GmbH$40K
  • Medtronic$32K
  • Impulse Dynamics (USA) Inc.$26K
  • Biotronik Inc.$25K
  • Elutia, Inc.$16K
  • plus $19K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis33$138,205
Boehringer Ingelheim International GmbH36$40,146
Medtronic(2 entities)34$32,010
Impulse Dynamics (USA) Inc.9$25,550
Biotronik Inc.114$25,273
Elutia, Inc.10$15,900
Abbott24$6,830
Boehringer Ingelheim Pharma GmbH & Co.kg1$6,506
Esperion Therapeutics, Inc.14$589
Johnson & Johnson28$505
Boehringer Ingelheim13$437
Inari Medical, Inc.6$399
AstraZeneca16$380
Merck18$362
Shockwave Medical, Inc5$347
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)10$280
Atricure, Inc.9$273
Abiomed5$243
Amgen8$226
Pfizer9$218
Kestra Medical Technology Services, Inc.2$189
Amarin Pharma, Inc.12$180
Cardiovascular Systems Inc.3$159
Penumbra, Inc.1$142
Astellas Pharma US Inc2$114
Kiniksa Pharmaceuticals, Ltd.3$79
Collegium Pharmaceutical, Inc.5$69
Sanofi-aventis U.S. LLC3$44
Lundbeck LLC2$34
Lexicon Pharmaceuticals, Inc.2$33
Alnylam Pharmaceuticals Inc.2$29
Actelion Pharmaceuticals US, Inc.1$28
E.r. Squibb & Sons, L.L.C.2$23
Bioventus LLC1$20
Biodelivery Sciences International, Inc.1$17
Bayer1$16
Alfasigma USA, Inc.1$14
Philips North America LLC1$14
Amryt Pharma Holdings Ltd1$13

How this compares

$295,896 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio →

Medicare billing

Part B allowed, 2024
$239,994
Medicare patients
1,339
Services billed
3,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Perrysburg

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →